Schlosser et al
Practical Implications of No IGF-1 Elevation: The absence of IGF-1 stimulation makes AOD-9604 suitable for populations who need to avoid IGF-1 elevation, including individuals with personal or family history of hormone-sensitive cancers, those concerned about accelerated aging through growth pathway activation, people seeking fat loss without anabolic muscle-building effects, individuals who have contraindications to growth hormone therapy, and those undergoing screening or monitoring where IGF-1 elevation would be problematic
However, it is always important to consult a doctor or pharmacist before taking any medicine
Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine
Follow-up evaluation Follow-up evaluation includes any of the previous exams completed during the initial evaluation that are required to monitor both response to and possible adverse effects from prescribed antihypertensive therapies, in addition to the assessment of any new symptoms of target organ damage and the assessment of patient adherence to therapy (Box 12-2)
Materials Today, 58, 135163
